Advances in Treatments in Muscular Dystrophies and Motor Neuron Disorders.

Neurologic Clinics
Bhaskar Roy, Robert C Griggs

Abstract

Increased understanding of disease pathophysiology and advances in gene therapies and drug technologies are revolutionizing treatment of muscular dystrophies and motor neuron disorders (MNDs). New drugs have been approved for Duchenne muscular dystrophy, spinal muscular atrophy, and amyotrophic lateral sclerosis. For other diseases, new targets have been identified, and new therapies are in clinical trials. The impact of such therapies will be fully understood only in the next decades. Cost burden and accessibility are major challenges in the wide application of new drugs. This article reviews advances in gene therapies, newly approved drugs, and therapeutic promises in muscular dystrophies and MNDs.

Citations

Sep 24, 2021·Pflügers Archiv : European journal of physiology·Kay Ohlendieck, Dieter Swandulla

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

JAMA Neurology
Peter B Kang, Robert C Griggs
Current Neurology and Neuroscience Reports
Neil Datta, Partha S Ghosh
JAMA : the Journal of the American Medical Association
T Furukawa, J B Peter
BMJ : British Medical Journal
A E Emery
Seminars in Veterinary Medicine and Surgery (small Animal)
N J SharpS B Lane
© 2021 Meta ULC. All rights reserved